lobbying_activities: 3199694

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3199694	b4d496a9-389a-4854-a9a7-75b1f8850d12	Q2	MARSHALL & POPP, LLC	401105121	ABBVIE INC.	2024	second_quarter	PHA	Issues related to the 340B drug discount program. Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169).	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2024-07-18T14:42:08-04:00